Keyword: Belgium

GlaxoSmithKline’s vaccines unit has been a bright spot for the company, but its performance doesn’t make it immune to staff cuts.

UCB, which recently paid $2.5 billion for an autoimmune drug candidate, will build a $333 million facility and staff it with 150 workers.

CDMO Minakem is in final qualifications to open its new closed-controlled environment high-containment production facility.

Belgium-based CDMO Kaneka Eurogentec, a unit of Japanese chemical giant Kaneka, will build a new biologics manufacturing facility.

A fight has emerged between countries vying for the economic lift and status that come with hosting the EMA.